- New injectable drug offers up to 93.9% reduction in heart cholesterol Ynetnews
- Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial Reuters
- Experts hail highly successful trial of Lilly’s cholesterol-busting drug lepodisiran upi.com
- Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk The New York Times
- Lilly’s lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels | Eli Lilly and Company Eli Lilly and Company
